Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Bispecific Antibody (bsAb): A Promising Immunotherapeutic agent.
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Desmond Omane Acheampong
ISBN: 9786202198189
Год издания: 2017
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 184
Издательство: LAP LAMBERT Academic Publishing
Цена: 39713 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Immunotherapy as a therapeutic option for cancer therapy has contributed immensely to the success gained so far in the fight against cancer. Notwithstanding, the use of immunotherapy is not a common practice in most health facilities that handle cancer cases, and can be attributed to the fact that these immunotherapeutic agents are usually expensive compared to alternative options. This book therefore discusses the possible formats used in developing immunotherapeutic agents. Introduction and the first three chapters introduce the reader to the general concept of cancer and the various forms of cancer. The common therapeutic options and their respective therapeutic agents are also covered under these chapters. This is necessary to equip novices with basic knowledge about cancer and bring them to an appreciable level of understanding with respect to the concept of immunotherapy. Chapter four explains the various formats for developing immunotherapeutic agents as well as applications of these agents. This book will diffuse the perception that developing immunotherapeutic agent is a herculean task if not impossible, and also whip up your interest immunotherapy.
Ключевые слова: antibody engineering, cancer therapy, immunotherapy, Bispecific Antibody